News from pfenex inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 14, 2018, 04:02 ET Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018

Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...

May 10, 2018, 04:02 ET Pfenex Reports First Quarter 2018 Results and Provides Business Update

Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression...

Apr 30, 2018, 04:15 ET Pfenex to Report First Quarter 2018 Results and Provide Business Update on Thursday, May 10th

Pfenex Inc. (NYSE American: PFNX) announced today that its first quarter 2018 financial results will be released on Thursday, May 10, 2018, after the ...

Apr 18, 2018, 05:00 ET Pfenex and NT Pharma Enter into a Development and License Agreement for Pfenex's PF708 Therapeutic Equivalent Candidate to Forteo®

Pfenex Inc. (NYSE AMERICAN: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (HKG:1011) today announced an agreement under which Pfenex...

Mar 15, 2018, 04:02 ET Pfenex Reports Fourth Quarter and Full Year 2017 Results and Provides Business Update

Pfenex Inc. (NYSE American: PFNX) is a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression...

Mar 13, 2018, 04:15 ET Pfenex Inc. to Present at Oppenheimer's 28th Annual Healthcare Conference

Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that the company will present at Oppenheimer's 28th Annual Healthcare Conference in New York City. ...

Mar 08, 2018, 04:15 ET Pfenex to Report Fourth Quarter and Full Year 2017 Results and Provide Business Update on Thursday, March 15, 2018

Pfenex Inc. (NYSE American: PFNX) announced today that its fourth quarter and full year 2017 financial results will be released on Thursday, March...

Feb 27, 2018, 04:15 ET Pfenex Inc. to Present at Barclay's 2018 Global Healthcare Conference

Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that the company will present at Barclay's 2018 Global Healthcare Conference in Miami Beach,...

Jan 04, 2018, 08:00 ET Pfenex Names Susan A. Knudson as Chief Financial Officer

Pfenex Inc. (NYSE American: PFNX) today announced the appointment of Susan A. Knudson as Chief Financial Officer, effective February 1, 2018. "After...

Dec 19, 2017, 07:00 ET Pfenex earns $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals

Pfenex Inc. (NYSE AMERICAN: PFNX) today announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide...

Nov 09, 2017, 17:15 ET Pfenex Inc. to Present at the Jefferies 2017 London Healthcare Conference

Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that it will be presenting at the Jefferies 2017 London Healthcare Conference on Wednesday,...

Oct 30, 2017, 16:05 ET Pfenex to Report Third Quarter 2017 Results and Provide Business Update on Thursday, November 9, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that its third quarter 2017 financial results will be released on Thursday, November 9, 2017, after the...

Sep 19, 2017, 07:00 ET Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017 ...

Sep 07, 2017, 17:45 ET Pfenex Announces Management Changes

Pfenex Inc. (NYSE MKT: PFNX), today announced that Dr. Paul Wagner, Chief Financial Officer, is leaving the Company effective October 13, 2017 to...

Sep 01, 2017, 07:00 ET Pfenex Reports New Employment Inducement Award Under NYSE MKT Listing Rules

Pfenex Inc. (NYSE MKT: PFNX) ("Pfenex" or the "Company"), a clinical-stage biotechnology company engaged in the development of biosimilar...

Aug 29, 2017, 06:00 ET Pfenex To Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12th, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the 19th Annual Rodman and Renshaw Global Investment Conference on...

Aug 23, 2017, 08:00 ET Pfenex To Present at the 6th Annual Liolios Gateway Conference on September 6th, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the 6th Annual Liolios Gateway Conference on September 6th, 2017 at 11:00...